Patent Board Kills 3 Ariosa Re-Exams Of Illumina Patent
The Patent Trial and Appeal Board ended three re-examinations of an Illumina Inc. diagnostic patent on Tuesday, finding the arguments against the patent were "substantially the same" as ones the board...To view the full article, register now.
Already a subscriber? Click here to view full article